113 related articles for article (PubMed ID: 4875711)
1. Experimental and clinical studies with diazoxide.
Wolff F; Hirsch E; Wales J; Viktora J
Ann N Y Acad Sci; 1968 Apr; 150(2):429-41. PubMed ID: 4875711
[No Abstract] [Full Text] [Related]
2. Studies on the mechanism of xylitol-induced insulin secretion in dogs. Effect of its infusion into the pancreatic artery, and the inhibition by epinephrine and diazoxide of xylitol-induced hyperinsulinaemia.
Kuzuya T; Kanazawa Y
Diabetologia; 1969 Aug; 5(4):248-57. PubMed ID: 4902720
[No Abstract] [Full Text] [Related]
3. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
4. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
5. AO44: an improved hyperglycemic agent.
Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
[No Abstract] [Full Text] [Related]
6. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
[No Abstract] [Full Text] [Related]
7. Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man.
Seltzer HS; Allen EW
Diabetes; 1969 Jan; 18(1):19-28. PubMed ID: 5761863
[No Abstract] [Full Text] [Related]
8. Diazoxide-induced long-term hyperglycemia. I. Preservation of B-cell insulin-releasing capacity.
Gomis R; Plaza C; Malaisse WJ
Diabetes Res; 1988 Dec; 9(4):183-6. PubMed ID: 3073904
[TBL] [Abstract][Full Text] [Related]
9. Biochemical aspects of the hyperglycemic action of diazoxide.
Senft G
Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
[No Abstract] [Full Text] [Related]
10. [Inhibitors of insulin secretion].
Frerichs H; Creutzfeldt C; Creutzfeldt W
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():105-23. PubMed ID: 5212265
[No Abstract] [Full Text] [Related]
11. Neonatal hyperglycemia following maternal diazoxide administration.
Milsap RL; Auld PA
JAMA; 1980 Jan; 243(2):144-5. PubMed ID: 6985679
[No Abstract] [Full Text] [Related]
12. The stimulus-secretion coupling of glucose-induced insulin release. 3. Uptake of 45 calcium by isolated islets of Langerhans.
Malaisse-Lagae F; Malaisse WJ
Endocrinology; 1971 Jan; 88(1):72-80. PubMed ID: 4921884
[No Abstract] [Full Text] [Related]
13. Diazoxide unmasks glucose inhibition of insulin release by counteracting entry of Ca2+.
Bergsten P; Gylfe E; Wesslén N; Hellman B
Am J Physiol; 1988 Oct; 255(4 Pt 1):E422-7. PubMed ID: 3052102
[TBL] [Abstract][Full Text] [Related]
14. [Antagonistic action of intestinal hormones and diazoxide on insulin secretion in humans].
Raptis S; Schröder KE; Faulhaber JD; Pfeiffer EF
Horm Metab Res; 1969 May; 1(3):116-21. PubMed ID: 4946718
[No Abstract] [Full Text] [Related]
15. [Inhibition of the insulo-pancreatic response to intravenous glucose and tolbutamide administration during infusion of epinephrine].
Laudicina E; Bompiani G; Angileri G; Mancuso L
Folia Endocrinol; 1967 Apr; 20(2):154-63. PubMed ID: 4864821
[No Abstract] [Full Text] [Related]
16. Insulin-glucagon ratio.
Unger RH
Isr J Med Sci; 1972 Mar; 8(3):252-7. PubMed ID: 4557377
[No Abstract] [Full Text] [Related]
17. Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man.
Graber AL; Porte D; Williams RH
Ann N Y Acad Sci; 1968 Apr; 150(2):303-8. PubMed ID: 4299222
[No Abstract] [Full Text] [Related]
18. Insulin I-131 disappearance rates following diazoxide, epinephrine and glucose administration.
Walfish PG
Ann N Y Acad Sci; 1968 Apr; 150(2):292-3. PubMed ID: 5243877
[No Abstract] [Full Text] [Related]
19. Nonketoacidotic hyperglycemia and coma during intravenous diazoxide therapy in uremia.
Charles MA; Danforth E
Diabetes; 1971 Jul; 20(7):501-3. PubMed ID: 5556285
[No Abstract] [Full Text] [Related]
20. Effect of diazoxide in plasma glucose and insulin concentrations after acute glycemic stimulation and intravenous tolbutamide.
Castro A; Grettie DP
Biochem Med; 1974 Apr; 9(4):354-62. PubMed ID: 4832203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
